New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

ITOS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.20%

Insider Buying (Last 12 Months): $41,850.00

Insider Selling (Last 12 Months): $5,691,000.00

iTeos Therapeutics Insider Trading History Chart

iTeos Therapeutics Share Price & Price History

^$9.84

▼ -0.07 (-0.71%)

As of 12/8/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

Invest in Autonomix today.

iTeos Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/12/2023	Matthew Gall	CFO	Buy	5,000	$8.37	$41,850.00	19,429
8/23/2023	Boxer Capital, Llc	Insider	Sell	350,000	$16.26	$5,691,000.00	1,804,058
6/9/2022	David Hallal	Director	Sell	1,171	$19.51	$22,846.21
5/11/2022	Aaron I Davis	Director	Sell	338,000	$18.25	$6,168,500.00	2,154,058
5/9/2022	Aaron I Davis	Director	Sell	225,000	$23.40	$5,265,000.00	2,592,058
5/2/2022	Aaron I Davis	Director	Sell	100,000	$27.49	$2,749,000.00	2,817,058
4/28/2022	Aaron I Davis	Director	Sell	150,000	$27.40	$4,110,000.00	3,042,058
4/18/2022	Michel Detheux	CEO	Sell	11,500	$31.87	$366,505.00	26,263
3/22/2022	Aaron I Davis	Director	Buy	30,000	$32.28	$968,400.00
3/22/2022	Michel Detheux	CEO	Sell	18,437	$34.17	$629,992.29
3/17/2022	Boxer Capital, Llc	Major Shareholder	Sell	575,201	$35.25	$20,275,835.25
3/11/2022	Joanne Jenkins Lager	Insider	Sell	3,500	$36.01	$126,035.00
3/1/2022	Yvonne McGrath	Insider	Sell	10,000	$36.76	$367,600.00
2/23/2022	Michel Detheux	CEO	Sell	14,500	$34.34	$497,930.00
2/11/2022	Joanne Jenkins Lager	Insider	Sell	3,500	$35.85	$125,475.00
1/25/2022	Michel Detheux	CEO	Sell	14,500	$35.68	$517,360.00
1/14/2022	Joanne Jenkins Lager	Insider	Sell	3,500	$39.32	$137,620.00
1/4/2022	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	128,550	$42.66	$5,483,943.00
1/3/2022	Detlev Biniszkiewicz	Director	Sell	3,500	$51.90	$181,650.00
1/3/2022	Joanne Jenkins Lager	Insider	Sell	7,000	$51.90	$363,300.00
12/27/2021	Matthew Gall	CFO	Sell	5,000	$46.45	$232,250.00
12/22/2021	Michel Detheux	CEO	Sell	16,163	$45.03	$727,819.89
12/20/2021	David Hallal	Director	Sell	50,000	$43.57	$2,178,500.00
12/20/2021	Michel Detheux	CEO	Sell	9,111	$43.94	$400,337.34
12/17/2021	Joanne Jenkins Lager	Insider	Sell	7,000	$41.00	$287,000.00
12/10/2021	Joanne Jenkins Lager	Insider	Sell	3,500	$34.50	$120,750.00
12/6/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	10,208	$32.59	$332,678.72
12/3/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	20,167	$34.79	$701,609.93
12/1/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	12,395	$34.28	$424,900.60
11/29/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	10,371	$34.49	$357,695.79
11/26/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	12,674	$35.75	$453,095.50
11/24/2021	Ansbert Gadicke	Major Shareholder	Sell	60,808	$36.29	$2,206,722.32
11/23/2021	Michel Detheux	CEO	Sell	14,500	$36.08	$523,160.00
11/22/2021	Ansbert Gadicke	Major Shareholder	Sell	35,333	$37.52	$1,325,694.16
11/18/2021	Joanne Jenkins Lager	Insider	Sell	28,000	$34.50	$966,000.00
11/3/2021	Michel Detheux	CEO	Sell	6,085	$28.89	$175,795.65
11/1/2021	Michel Detheux	CEO	Sell	81	$28.00	$2,268.00
10/21/2021	Michel Detheux	CEO	Sell	196	$28.00	$5,488.00
10/19/2021	Michel Detheux	CEO	Sell	201	$28.00	$5,628.00
10/18/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	6,167	$27.14	$167,372.38
10/15/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	10,932	$27.62	$301,941.84
10/15/2021	Michel Detheux	CEO	Sell	1,635	$28.01	$45,796.35
10/13/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	20,929	$27.13	$567,803.77
10/11/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	48,812	$27.24	$1,329,638.88
10/7/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	1,149	$27.00	$31,023.00
10/4/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	20,711	$27.06	$560,439.66
9/30/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	2,292	$27.00	$61,884.00
9/27/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	11,625	$27.09	$314,921.25
9/24/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	4,913	$27.81	$136,630.53
9/23/2021	Michel Detheux	CEO	Sell	5,322	$28.16	$149,867.52
9/22/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	14,294	$27.54	$393,656.76
9/20/2021	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	24,303	$27.49	$668,089.47
9/17/2021	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	45,698	$28.82	$1,317,016.36
9/15/2021	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	24,104	$27.80	$670,091.20
9/13/2021	Ansbert Gadicke	Major Shareholder	Sell	35,785	$27.64	$989,097.40
9/9/2021	Ansbert Gadicke	Major Shareholder	Sell	38,028	$28.97	$1,101,671.16
9/7/2021	Ansbert Gadicke	Major Shareholder	Sell	50,996	$29.18	$1,488,063.28
9/1/2021	Michel Detheux	CEO	Sell	8,684	$28.30	$245,757.20
8/30/2021	Michel Detheux	CEO	Sell	2,322	$28.01	$65,039.22	132,104
8/27/2021	Michel Detheux	CEO	Sell	8,248	$28.17	$232,346.16
8/25/2021	Michel Detheux	CEO	Sell	861	$28.00	$24,108.00
8/23/2021	Michel Detheux	CEO	Sell	7,499	$28.06	$210,421.94	141,438
6/16/2021	Matthew Gall	CFO	Buy	5,000	$26.09	$130,450.00	5,000
6/14/2021	Michel Detheux	CEO	Sell	29,000	$28.50	$826,500.00	152,874
6/8/2021	Yvonne McGrath	VP	Sell	7,927	$20.00	$158,540.00	7,927
5/24/2021	Yvonne McGrath	VP	Sell	7,927	$21.92	$173,759.84	7,927
4/9/2021	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	119	$29.99	$3,568.81
4/7/2021	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	5,783	$32.55	$188,236.65

All the trading advice you’ve ever received boils down to this

From DTI Trader | Ad

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

Drop everything and learn about the Income Calendar now.

SEC Filings (Institutional Ownership Changes) for iTeos Therapeutics (NASDAQ:ITOS)

97.16% of iTeos Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

iTeos Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/6/2023	Citigroup Inc.	86,334	$0.95M	0.0%	-63.2%	0.241%
11/30/2023	American Century Companies Inc.	51,555	$0.57M	0.0%	-27.4%	0.144%
11/24/2023	Deutsche Bank AG	24,631	$0.27M	0.0%	+11.6%	0.069%
11/22/2023	Public Sector Pension Investment Board	32,728	$0.36M	0.0%	-25.3%	0.091%
11/21/2023	Comerica Bank	12,243	$0.13M	0.0%	N/A	0.034%
11/17/2023	Jacobs Levy Equity Management Inc.	459,712	$5.03M	0.0%	-6.3%	1.285%
11/15/2023	Sectoral Asset Management Inc.	155,075	$1.70M	0.3%	+5.8%	0.433%
11/15/2023	Adage Capital Partners GP L.L.C.	20,000	$0.22M	0.0%	N/A	0.056%
11/15/2023	AQR Capital Management LLC	59,380	$0.65M	0.0%	+6.0%	0.166%
11/14/2023	683 Capital Management LLC	810,000	$8.87M	0.7%	+38.5%	2.264%
11/14/2023	Deerfield Management Company L.P. Series C	723,000	$7.92M	0.2%	N/A	2.021%
11/14/2023	California State Teachers Retirement System	26,022	$0.29M	0.0%	-9.2%	0.073%
11/14/2023	Tower Research Capital LLC TRC	2,648	$29K	0.0%	+168.3%	0.007%
11/14/2023	Trexquant Investment LP	33,549	$0.37M	0.0%	+10.8%	0.094%
11/14/2023	Profund Advisors LLC	15,429	$0.17M	0.0%	-8.3%	0.043%
11/13/2023	Algert Global LLC	96,180	$1.05M	0.0%	+131.3%	0.269%
11/13/2023	Northern Trust Corp	277,235	$3.04M	0.0%	+3.9%	0.775%
11/13/2023	Hsbc Holdings PLC	13,070	$0.14M	0.0%	N/A	0.037%
11/13/2023	Invesco Ltd.	207,165	$2.27M	0.0%	-3.8%	0.579%
11/13/2023	WINTON GROUP Ltd	33,433	$0.37M	0.0%	+173.8%	0.093%
11/13/2023	Rafferty Asset Management LLC	85,189	$0.93M	0.0%	-1.6%	0.238%
11/13/2023	PNC Financial Services Group Inc.	2,287	$25K	0.0%	+131.5%	0.006%
11/9/2023	Rhumbline Advisers	68,997	$0.76M	0.0%	+6.3%	0.193%
11/9/2023	Deutsche Bank AG	24,631	$0.27M	0.0%	+11.6%	0.069%
11/9/2023	Citigroup Inc.	86,334	$0.95M	0.0%	-63.2%	0.241%
11/9/2023	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	17,702	$0.19M	0.0%	-36.5%	0.049%
11/9/2023	UBS Group AG	23,126	$0.25M	0.0%	-48.3%	0.065%
11/9/2023	Jupiter Asset Management Ltd.	30,706	$0.34M	0.0%	-37.2%	0.086%
11/8/2023	Charles Schwab Investment Management Inc.	210,171	$2.30M	0.0%	+10.1%	0.587%
11/8/2023	Massachusetts Financial Services Co. MA	78,243	$0.86M	0.0%	-3.7%	0.219%
11/8/2023	Amalgamated Bank	10,574	$0.12M	0.0%	+14.7%	0.030%
11/7/2023	Quantbot Technologies LP	4,700	$51K	0.0%	N/A	0.013%
11/7/2023	New York State Common Retirement Fund	5,255	$58K	0.0%	-79.1%	0.015%
11/7/2023	Barclays PLC	322,322	$3.53M	0.0%	+2.4%	0.901%
11/6/2023	Los Angeles Capital Management LLC	105,554	$1.16M	0.0%	-4.1%	0.295%
11/4/2023	Syon Capital LLC	12,368	$0.14M	0.0%	N/A	0.035%
11/2/2023	Principal Financial Group Inc.	152,342	$1.67M	0.0%	+3.8%	0.426%
10/31/2023	Panagora Asset Management Inc.	146,276	$1.60M	0.0%	+20.9%	0.409%
10/24/2023	Bank of New York Mellon Corp	278,959	$3.06M	0.0%	+6.5%	0.780%
10/18/2023	Exchange Traded Concepts LLC	8,494	$93K	0.0%	-11.7%	0.024%
10/11/2023	Vontobel Holding Ltd.	155,075	$1.70M	0.0%	+5.8%	0.433%
9/21/2023	Barclays PLC	314,880	$4.17M	0.0%	+22.5%	0.880%
8/22/2023	Virginia Retirement Systems ET AL	42,000	$0.56M	0.0%	N/A	0.117%
8/21/2023	California State Teachers Retirement System	28,667	$0.38M	0.0%	+10.5%	0.080%
8/16/2023	Nuveen Asset Management LLC	75,711	$1M	0.0%	-22.2%	0.212%
8/15/2023	Alliancebernstein L.P.	37,060	$0.49M	0.0%	+46.5%	0.104%
8/15/2023	State of Tennessee Treasury Department	16,137	$0.21M	0.0%	+11.2%	0.045%
8/15/2023	Worth Venture Partners LLC	10,900	$0.14M	0.1%	N/A	0.030%
8/15/2023	Goldman Sachs Group Inc.	643,665	$8.52M	0.0%	+46.9%	1.799%
8/15/2023	Readystate Asset Management LP	88,391	$1.17M	0.1%	N/A	0.247%
8/15/2023	Royal Bank of Canada	2,586	$34K	0.0%	+94.3%	0.007%
8/15/2023	C M Bidwell & Associates Ltd.	3,929	$52K	0.0%	N/A	0.011%
8/14/2023	NinePointTwo Capital LLC	17,677	$0.23M	0.1%	-9.4%	0.049%
8/14/2023	683 Capital Management LLC	585,000	$7.75M	0.6%	+21.9%	1.635%
8/14/2023	Marshall Wace LLP	35,429	$0.47M	0.0%	-35.6%	0.099%
8/14/2023	State of Wisconsin Investment Board	65,034	$0.86M	0.0%	+48.6%	0.182%
8/14/2023	State Street Corp	1,565,202	$20.72M	0.0%	-14.3%	4.374%
8/14/2023	WINTON GROUP Ltd	12,212	$0.16M	0.0%	-33.7%	0.034%
8/14/2023	Nuveen Asset Management LLC	75,711	$1M	0.0%	-22.2%	0.212%
8/11/2023	Renaissance Technologies LLC	413,200	$5.47M	0.0%	+25.3%	1.155%
8/11/2023	BlackRock Inc.	4,680,194	$61.97M	0.0%	+4.9%	13.080%
8/11/2023	Panagora Asset Management Inc.	121,039	$1.60M	0.0%	+3.7%	0.338%
8/11/2023	Sectoral Asset Management Inc.	146,576	$1.94M	0.3%	+65.9%	0.410%
8/11/2023	The Manufacturers Life Insurance Company	10,296	$0.14M	0.0%	N/A	0.029%
8/11/2023	Franklin Resources Inc.	12,072	$0.16M	0.0%	N/A	0.034%
8/11/2023	Trexquant Investment LP	30,281	$0.40M	0.0%	+117.3%	0.085%
8/11/2023	Geode Capital Management LLC	502,012	$6.65M	0.0%	+4.3%	1.403%
8/11/2023	JPMorgan Chase & Co.	20,448	$0.27M	0.0%	-96.1%	0.057%
8/11/2023	Northern Trust Corp	266,838	$3.53M	0.0%	+5.9%	0.746%
8/11/2023	ExodusPoint Capital Management LP	15,418	$0.20M	0.0%	N/A	0.043%
8/10/2023	Great West Life Assurance Co. Can	21,395	$0.28M	0.0%	-8.8%	0.060%
8/10/2023	Profund Advisors LLC	16,823	$0.22M	0.0%	-24.1%	0.047%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	14,004	$0.19M	0.0%	-9.3%	0.039%
8/10/2023	Quadrant Capital Group LLC	2,194	$29K	0.0%	+9,041.7%	0.006%
8/10/2023	Charles Schwab Investment Management Inc.	190,913	$2.53M	0.0%	+4.3%	0.534%
8/10/2023	Citigroup Inc.	234,667	$3.11M	0.0%	-18.8%	0.656%
8/9/2023	Dimensional Fund Advisors LP	578,649	$7.66M	0.0%	+39.2%	1.618%
8/9/2023	Swiss National Bank	50,600	$0.67M	0.0%	+19.9%	0.141%
8/9/2023	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	27,894	$0.37M	0.0%	+7.3%	0.078%
8/8/2023	Rhumbline Advisers	64,908	$0.86M	0.0%	+6.0%	0.182%
8/8/2023	Candriam S.C.A.	611,547	$8.10M	0.1%	-17.3%	1.710%
8/7/2023	Principal Financial Group Inc.	146,787	$1.94M	0.0%	-5.4%	0.410%
8/3/2023	Los Angeles Capital Management LLC	110,022	$1.46M	0.0%	+2.6%	0.308%
8/3/2023	Barclays PLC	314,880	$4.17M	0.0%	+22.5%	0.881%
8/2/2023	Yousif Capital Management LLC	21,158	$0.28M	0.0%	-4.1%	0.059%
8/2/2023	Bank of Montreal Can	171,389	$3.10M	0.0%	N/A	0.479%
7/31/2023	Strs Ohio	15,100	$0.20M	0.0%	-56.5%	0.042%
7/27/2023	Victory Capital Management Inc.	98,782	$1.31M	0.0%	+17.0%	0.276%
7/27/2023	New York State Teachers Retirement System	27,200	$0.36M	0.0%	-7.5%	0.076%
7/27/2023	EA Series Trust	101,304	$1.34M	0.0%	N/A	0.283%
7/24/2023	Allspring Global Investments Holdings LLC	15,150	$0.20M	0.0%	-14.5%	0.042%
7/24/2023	Vontobel Holding Ltd.	146,576	$1.94M	0.0%	+65.9%	0.410%
7/20/2023	Exchange Traded Concepts LLC	9,624	$0.13M	0.0%	N/A	0.027%
7/18/2023	Louisiana State Employees Retirement System	13,000	$0.17M	0.0%	+14.0%	0.036%
7/18/2023	Allspring Global Investments Holdings LLC	15,150	$0.20M	0.0%	-14.5%	0.042%
5/22/2023	Ameriprise Financial Inc.	138,640	$1.89M	0.0%	+13.7%	0.388%
5/18/2023	JPMorgan Chase & Co.	526,157	$7.16M	0.0%	-9.9%	1.471%
5/18/2023	New York State Common Retirement Fund	31,319	$0.43M	0.0%	-33.9%	0.088%
5/17/2023	Thrivent Financial for Lutherans	24,326	$0.33M	0.0%	-3.4%	0.068%
5/16/2023	State Street Corp	1,827,391	$24.87M	0.0%	+5.2%	5.110%

Data available starting January 2016

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells, natural killer cells, and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $9.84

$9.66

$10.02

50 Day Range

MA: $9.67

$8.58

$10.65

52 Week Range

Now: $9.84

$8.20

$23.00

Volume

384,311 shs

Average Volume

291,685 shs

Market Capitalization

$352.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.1

Who are the company insiders with the largest holdings of iTeos Therapeutics?: iTeos Therapeutics' top insider shareholders include:
Aaron I Davis (Director)
Boxer Capital, Llc (Insider)
Michel Detheux (CEO)
Matthew Gall (CFO)
Bioventures 2018 LP Mpm (Major Shareholder)
Boxer Capital, Llc (Major Shareholder)
David Hallal (Director)
Detlev Biniszkiewicz (Director)
Joanne Jenkins Lager (Insider)
Yvonne Mcgrath (Insider)
Learn More about top insider investors at iTeos Therapeutics.
Who are the major institutional investors of iTeos Therapeutics?: iTeos Therapeutics' top institutional shareholders include:
683 Capital Management LLC — 2.26%
Deerfield Management Company L.P. Series C — 2.02%
Jacobs Levy Equity Management Inc. — 1.28%
Barclays PLC — 0.90%
Bank of New York Mellon Corp — 0.78%
Northern Trust Corp — 0.77%
Learn More about top institutional investors of iTeos Therapeutics stock.
Which institutional investors are selling iTeos Therapeutics stock?: Within the last quarter, ITOS stock was sold by these institutional investors:
Citigroup Inc.
Citigroup Inc.
Jacobs Levy Equity Management Inc.
UBS Group AG
New York State Common Retirement Fund
American Century Companies Inc.
Jupiter Asset Management Ltd.
Public Sector Pension Investment Board
Which institutional investors are buying iTeos Therapeutics stock?: During the last quarter, ITOS stock was purchased by institutional investors including:
Deerfield Management Company L.P. Series C
683 Capital Management LLC
Algert Global LLC
Panagora Asset Management Inc.
WINTON GROUP Ltd
Adage Capital Partners GP L.L.C.
Charles Schwab Investment Management Inc.
Bank of New York Mellon Corp
Within the last year, these company insiders have bought iTeos Therapeutics stock:
Aaron I Davis (Director)
Boxer Capital, Llc (Insider)
Learn More investors buying iTeos Therapeutics stock.